Lumina Pharmaceuticals
Boston, US · Founded 2025 · Delaware corporation
Lumina Pharmaceuticals is a clinical-stage company that develops diagnostic and therapeutic radiopharmaceuticals using peptide technology.
Founders & leadership
CF
Cara FerreiraExecutive
ES
Eric S. HoffmanChief Business Officer
AG
Alma Gregory SorensenNamed on SEC filing
Board
PC
Peter CaravanBoard director
Reported raises · per SEC filings
Form D private placements$2M disclosed across 1 round · 2025
▶$2MraisedJun 2025 · 2 investors · PharmaceuticalsRule 506(b)
▶$2MraisedJun 2025 · 2 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Alma Gregory SorensenExecutive Officer, Director
- Peter CaravanDirector
- Cara FerreiraExecutive Officer, Director
- Offering amount
- $2M
- Amount sold
- $2M
- Minimum investment
- $25K
- First sale
- May 2025
- Incorporated
- Corporation, Delaware, 2025
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 4
by search overlap
Lumos Pharma5 shared keywordsLumos Pharma is a clinical-stage biopharmaceutical company developing therapies for rare diseases, with a lead candidate targeting Pediatric Growth Hormone Deficiency. It also pursues partnerships to in-license or acquire additional rare disease therapeutic candidates for development and commercialization.
Lumen5 shared keywordsLumen develops orally delivered antibody drugs using engineered spirulina, a patented biologic platform that reduces manufacturing costs and timelines compared to conventional biologics. The company serves biopharma customers seeking alternatives to traditional drug manufacturing.
Lantern Pharma5 shared keywordsLantern Pharma is a pharmaceutical biotechnology company that applies machine learning and AI to oncology drug development, using data-driven hypothesis testing with in vitro and in vivo models. Its approach stratifies patient populations into responders and non-responders to de-risk clinical trials, develop companion diagnostics, and improve the likelihood of FDA approval at reduced cost.
Neumora Therapeutics4 shared keywordsNeumora is a clinical research company developing investigational medications, with a focus on conducting clinical trials to obtain regulatory approval and make treatments available to patients.
Companies competing with Lumina Pharmaceuticals for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Frequently asked questions
- What does Lumina Pharmaceuticals do?
- Lumina Pharmaceuticals is a clinical-stage company that develops diagnostic and therapeutic radiopharmaceuticals using peptide technology.
- How much funding has Lumina Pharmaceuticals raised?
- Lumina Pharmaceuticals has disclosed $2M raised across 1 round.
- Where is Lumina Pharmaceuticals headquartered?
- Lumina Pharmaceuticals is headquartered in Boston, US.